Inhibition of human matriptase by eglin c variants |
| |
Authors: | Désilets Antoine Longpré Jean-Michel Beaulieu Marie-Eve Leduc Richard |
| |
Institution: | Department of Pharmacology, Faculty of Medicine and Health Sciences, Université de Sherbrooke, Sherbrooke, Que., Canada J1H 5N4 |
| |
Abstract: | Based on the enzyme specificity of matriptase, a type II transmembrane serine protease (TTSP) overexpressed in epithelial tumors, we screened a cDNA library expressing variants of the protease inhibitor eglin c in order to identify potent matriptase inhibitors. The most potent of these, R1K4′-eglin, which had the wild-type Pro45 (P1 position) and Tyr49 (P4′ position) residues replaced with Arg and Lys, respectively, led to the production of a selective, high affinity (Ki of 4 nM) and proteolytically stable inhibitor of matriptase. Screening for eglin c variants could yield specific, potent and stable inhibitors to matriptase and to other members of the TTSP family. |
| |
Keywords: | TTSP Type II transmembrane serine protease IMAC immobilized metal-chelate affinity chromatography MUGB 4-methylumbelliferyl p-guanidino benzoate HAT human airway trypsin-like protease AMC 7-amino-4-methylcoumarin |
本文献已被 ScienceDirect PubMed 等数据库收录! |
|